Tarka and Prolia drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Tarka (trandolapril; verapamil hydrochloride) and Prolia (denosumab). Common drug interactions include ankle fracture among females and ankle fracture among males.

The phase IV clinical study analyzes what interactions people have when they take Tarka and Prolia. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.

What is Tarka?

Tarka has active ingredients of trandolapril; verapamil hydrochloride. It is often used in high blood pressure. eHealthMe is studying from 2,409 Tarka users. Check the latest studies of Tarka.

What is Prolia?

Prolia has active ingredients of denosumab. It is often used in osteoporosis. eHealthMe is studying from 151,389 Prolia users. Check the latest studies of Prolia.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 01, 2026

12 people who take Tarka and Prolia together, and have interactions are studied.

Tarka and Prolia drug interactions.

What are the common drug interactions of Tarka and Prolia, by gender? *:

female:

  1. Ankle fracture
  2. Bone density decreased
  3. Bone loss
  4. Emotional distress
  5. Foot fracture
  6. Osteopenia (a condition where bone mineral density is lower than normal)
  7. Rib fracture
  8. Vitamin d deficiency
  9. Fall
  10. Intervertebral disc degeneration (spinal disc degeneration)

male:

  1. Ankle fracture
  2. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  3. Fibromyalgia (a long-term condition which causes pain all over the body)
  4. Fibula fracture
  5. Foot fracture
  6. Intervertebral disc degeneration (spinal disc degeneration)
  7. Intervertebral disc protrusion (spinal disc protrusion)
  8. Joint injury
  9. Multiple fractures
  10. Neck pain

What are the common drug interactions of Tarka and Prolia, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

  1. Ankle fracture
  2. Bone density decreased
  3. Arthralgia (joint pain)
  4. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  5. Coccydynia (pain in the coccyx or tailbone area)
  6. Erythema (redness of the skin)
  7. Hypovitaminosis (any of several diseases caused by deficiency of one or more vitamins)
  8. Joint effusion (presence of extra fluid in joint covering)
  9. Joint swelling
  10. Musculoskeletal pain (pain affects the bones, muscles, ligaments, tendons, and nerves)

What are the existing conditions these people have? *

  1. Migraine (headache): 9 people, 75.00%
  2. Fibromyalgia (a long-term condition which causes pain all over the body): 9 people, 75.00%
  3. Pain: 8 people, 66.67%
  4. Bone Disorder: 8 people, 66.67%
  5. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 16.67%
  6. Arthritis (form of joint disorder that involves inflammation of one or more joints): 2 people, 16.67%
  7. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 8.33%
  8. Radiculitis Lumbosacral (inflammation of nerve root at labosacral vertebrea): 1 person, 8.33%
  9. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 1 person, 8.33%
  10. Fluid Retention (an abnormal accumulation of fluid in the blood): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Tarka and Prolia?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Tarka and Prolia:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Tarka:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Prolia:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Tarka and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Prolia and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on trandolapril; verapamil hydrochloride and denosumab (the active ingredients of Tarka and Prolia, respectively), and Tarka and Prolia (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: